Search

Your search keyword '"Frances McSherry"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Frances McSherry" Remove constraint Author: "Frances McSherry" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
98 results on '"Frances McSherry"'

Search Results

1. Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

2. Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution Experience

3. Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis

4. Single fraction stereotactic radiosurgery for multiple brain metastases

5. Table S2 from Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

6. Data from Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

7. Figure S2 from Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

9. Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP)

10. Spiritual well-being and its association with health-related quality of life in primary brain tumor patients

11. Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide

12. Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population

13. BIOM-20. TUMOR-INTRINSIC AND PERIPHERAL FEATURES ASSOCIATE WITH SURVIVAL AFTER POLIO VIROTHERAPY IN RECURRENT GBM

14. Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis

15. Recurrent Glioblastoma Treated with Recombinant Poliovirus

16. Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas

17. Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

18. Single fraction stereotactic radiosurgery for multiple brain metastases

19. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis

20. ATIM-27. TUMOR MUTATIONAL BURDEN PREDICTS RESPONSE TO ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF TRANSCRIPTIONAL AND IMMUNOLOGICAL CORRELATES

21. Second primary cancers in long-term survivors of glioblastoma

22. A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

23. Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ)

24. QOLP-13. PSYCHOSOCIAL DISTRESS IN PATIENTS WITH RECURRENT MENINGIOMAS

25. RBTT-02. ENHANCING VACCINE RESPONSES WITH DOSE-INTENSIFIED TEMOZOLOMIDE IN GLIOBLASTOMA: INITIATION OF THE I-ATTAC TRIAL

26. HGG-22. PHASE 1b STUDY POLIO VACCINE SABIN-RHINOVIRUS POLIOVIRUS (PVSRIPO) FOR RECURRENT MALIGNANT GLIOMA IN CHILDREN

27. Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma

28. Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer

29. A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population

30. Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients

31. Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxorubicin-containing chemotherapy: a pilot study

32. Outcomes Following Adjuvant Radiation Therapy in Elderly Patients with Glioblastoma: A Retrospective Single Institution Analysis

33. Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial

34. Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice

35. Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial

36. Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis

37. Insomnia and its associations in patients with recurrent glial neoplasms

38. Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

39. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial

40. QOLP-17. REVIEW AND META-ANALYSIS OF NAUSEA AND VOMITING TRIALS FOR MALIGNANT GLIOMAS

41. ATIM-27. INTRATUMORAL ADMINISTRATION OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF MUTATIONAL RESPONSE CORRELATES

42. Long-term Outcomes and Imaging Response for Image-Guided Stereotactic Radiosurgery (IG-SRS) of Brain Arteriovenous Malformations (AVM)

43. Text messaging and activity tracker motivation program to increase physical activity in cancer survivors

44. ATCT-01PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)

45. Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

46. Single-Fraction Radiosurgery for 4 or More Brain Metastases

47. Can screening for genetic markers improve peripheral artery bypass patency?

48. Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure

49. Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma

50. QLIF-05. A SINGLE INSTITUTION’S EXPERIENCE EXPLORING THE ASSOCIATION OF INTEGRATIVE MEDICINE AND SURVIVORSHIP IN GLIOBLASTOMA

Catalog

Books, media, physical & digital resources